Royer Pierre-Joseph, Olivera-Botello Gustavo, Koutsokera Angela, Aubert John-David, Bernasconi Eric, Tissot Adrien, Pison Christophe, Nicod Laurent, Boissel Jean-Pierre, Magnan Antoine
1 L'institut du thorax, Nantes, France. 2 Novadiscovery, Lyon, France. 3 Service de Pneumologie, Centre de Transplantation, Lausanne, Switzerland. 4 Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, CHU Grenoble, France. 5 Inserm1055, France. 6 Université Joseph Fourier Grenoble, France.
Transplantation. 2016 Sep;100(9):1803-14. doi: 10.1097/TP.0000000000001215.
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans syndrome or the recently described restrictive allograft syndrome. Although numerous risk factors have been identified so far, the physiopathological mechanisms of CLAD remain poorly understood. We investigate here the immune mechanisms involved in the development of CLAD after lung transplantation. We explore the innate or adaptive immune reactions induced by the allograft itself or by the environment and how they lead to allograft dysfunction. Because current literature suggests bronchiolitis obliterans syndrome and restrictive allograft syndrome as 2 distinct entities, we focus on the specific factors behind one or the other syndromes. Chronic lung allograft dysfunction is a multifactorial disease that remains irreversible and unpredictable so far. We thus finally discuss the potential of systems-biology approach to predict its occurrence and to better understand its underlying mechanisms.
慢性肺移植功能障碍(CLAD)是肺移植后长期生存的主要限制因素。慢性肺移植功能障碍表现为闭塞性细支气管炎综合征或最近描述的限制性移植综合征。尽管到目前为止已确定了众多风险因素,但CLAD的生理病理机制仍知之甚少。我们在此研究肺移植后CLAD发生过程中涉及的免疫机制。我们探讨同种异体移植物本身或环境诱导的先天性或适应性免疫反应,以及它们如何导致同种异体移植物功能障碍。由于当前文献表明闭塞性细支气管炎综合征和限制性移植综合征是两种不同的实体,我们专注于这两种综合征背后的特定因素。慢性肺移植功能障碍是一种多因素疾病,迄今为止仍然不可逆转且无法预测。因此,我们最后讨论系统生物学方法在预测其发生及更好理解其潜在机制方面的潜力。